Check out the video version of this podcast for a sneak peak of Cafer's Psychopharmacology 2nd edition, in the works for 2025.
![Data visualization of medications for EMR by Jason Cafer MD](https://static.wixstatic.com/media/966baf_50e3ace6954845b6b1747d7e7fe59fb9~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_50e3ace6954845b6b1747d7e7fe59fb9~mv2.png)
![Duloxetine Cymbalta by Jason Cafer MD](https://static.wixstatic.com/media/966baf_98ed3347c0fd48c0bad46917e6e57f70~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_98ed3347c0fd48c0bad46917e6e57f70~mv2.png)
![Lumateperone Caplyta by Jason Cafer MD](https://static.wixstatic.com/media/966baf_6def799f7d1b4f739dcfbad2362a69a5~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_6def799f7d1b4f739dcfbad2362a69a5~mv2.png)
![Quetiapine Seroquel by Jason Cafer MD](https://static.wixstatic.com/media/966baf_8b2723b11bed4f5496d585ad1c28ab90~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_8b2723b11bed4f5496d585ad1c28ab90~mv2.png)
![Brexpiprazole Rexulti by Jason Cafer MD](https://static.wixstatic.com/media/966baf_839df7138b21451e845afc8670c83926~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_839df7138b21451e845afc8670c83926~mv2.png)
![Fluvoxamine Luvox by Jason Cafer MD](https://static.wixstatic.com/media/966baf_221da33115074ea9951e7e9243e40fc8~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_221da33115074ea9951e7e9243e40fc8~mv2.png)
![Carbamazepine Tegretol by Jason Cafer MD](https://static.wixstatic.com/media/966baf_6655ff9993544b539f14ae9131aa01f1~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_6655ff9993544b539f14ae9131aa01f1~mv2.png)
![Induction versus inhibition / Inducers vs Inhibitors CYP450](https://static.wixstatic.com/media/966baf_6ae6ae8599dc49f1ac61ba1e51263b93~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_6ae6ae8599dc49f1ac61ba1e51263b93~mv2.png)
![CYP1A2 interaction](https://static.wixstatic.com/media/966baf_337cf41622c545e5a11acbe09a88e7a6~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_337cf41622c545e5a11acbe09a88e7a6~mv2.png)
![Carbamazepine Tegretol interactions CYP1A2](https://static.wixstatic.com/media/966baf_847ee6e1b03c4525b7cc930e2b05837f~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_847ee6e1b03c4525b7cc930e2b05837f~mv2.png)
![Interaction between smoking and duloxetine (Cymbalta) by Jason Cafer MD](https://static.wixstatic.com/media/966baf_f99470ebfe7c43f28f6c73c0a20cc95a~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_f99470ebfe7c43f28f6c73c0a20cc95a~mv2.png)
![Interaction between Fluvoxamine (Luvox) and lumateperone (Caplyta) by Jason Cafer MD](https://static.wixstatic.com/media/966baf_2dfb72974d374bf4842949c0a8858782~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_2dfb72974d374bf4842949c0a8858782~mv2.png)
![CYP2D6 interactions](https://static.wixstatic.com/media/966baf_11f6d4cc216a4c6fbb7ad822da16a9b0~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_11f6d4cc216a4c6fbb7ad822da16a9b0~mv2.png)
![CYP2D6 prodrugs / prodrug interactions](https://static.wixstatic.com/media/966baf_8b7a485e11fe49038cde7a45f97b950d~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_8b7a485e11fe49038cde7a45f97b950d~mv2.png)
![Inducers of CYP2D6 by Jason Cafer MD](https://static.wixstatic.com/media/966baf_7d1fe3c5da9944ea89d229295edae68f~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_7d1fe3c5da9944ea89d229295edae68f~mv2.png)
![Brexpiprazole (Rexulti) and CYP2D6 normal, ultrarapid, and poor metabolizers / pharmacogenetic testing](https://static.wixstatic.com/media/966baf_be7b2e91ed974302933d4ac97aba82f0~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_be7b2e91ed974302933d4ac97aba82f0~mv2.png)
![CYP2D6 poor metabolizers and tramadol, codeine, and tamoxifen](https://static.wixstatic.com/media/966baf_e59b7dff98604e4d8b212015d067322c~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_e59b7dff98604e4d8b212015d067322c~mv2.png)
![CYP2C19 interactions](https://static.wixstatic.com/media/966baf_cfade041f2774709b8ab79dfda520364~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_cfade041f2774709b8ab79dfda520364~mv2.png)
![CYP2C19 fluvoxamine and tricyclic antidepressant interactions](https://static.wixstatic.com/media/966baf_b3ba3d8962bf43778cc05af04c067831~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_b3ba3d8962bf43778cc05af04c067831~mv2.png)
![CYP2C19 poor and ultrarapid metabolizers by Jason Cafer MD](https://static.wixstatic.com/media/966baf_b66b2e0cabf54c91b3e213014d647732~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_b66b2e0cabf54c91b3e213014d647732~mv2.png)
![Stahl's Essential Psychopharmacology ballicules](https://static.wixstatic.com/media/966baf_9c5fd451fbfe409ab71f3fcc76a87cfe~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_9c5fd451fbfe409ab71f3fcc76a87cfe~mv2.png)
![Cafer's Psychopharmacology Second Edition - Visualize to Memorize psychiatric medications](https://static.wixstatic.com/media/966baf_5ab55d41ffc045449ea680a00db1626a~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_5ab55d41ffc045449ea680a00db1626a~mv2.png)
![Neurotransmitters from Stahl's Essential Psychopharmacology](https://static.wixstatic.com/media/966baf_a621ed1bb53a45639a85e169a9776c7f~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_a621ed1bb53a45639a85e169a9776c7f~mv2.png)
![Alternative to Stephen Stahl's Essential Psychopharmacology](https://static.wixstatic.com/media/966baf_b535ee5d0d0540248426190ca36b0d6e~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_b535ee5d0d0540248426190ca36b0d6e~mv2.png)
![Alternative to Stahl's Essential Psychopharmacology](https://static.wixstatic.com/media/966baf_c4858e2a22fc4ceb83138f30609c7c07~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_c4858e2a22fc4ceb83138f30609c7c07~mv2.png)
![Bioengineering of psychotropic medications by Jason Cafer MD including mirtazapine (Remeron)](https://static.wixstatic.com/media/966baf_b1c306edf0b84b13827ce2620e0fcdbf~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_b1c306edf0b84b13827ce2620e0fcdbf~mv2.png)
![Alternative to Stahl's essential psychopharmacology for pharmacokinetic interactions](https://static.wixstatic.com/media/966baf_750c4f325a244df7ae2d2efaefa29a03~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_750c4f325a244df7ae2d2efaefa29a03~mv2.png)
![Stephen Stahl's Essential Psychopharmacology alternative](https://static.wixstatic.com/media/966baf_5b29e38023f04e78a5c6ee3a0edad138~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_5b29e38023f04e78a5c6ee3a0edad138~mv2.png)
![CYP inhibitor and substrate explanation](https://static.wixstatic.com/media/966baf_2ab42f6ab9f144d7a8b760bc4013006d~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_2ab42f6ab9f144d7a8b760bc4013006d~mv2.png)
![CYP inducers and substrates](https://static.wixstatic.com/media/966baf_1429e6c427924064b77beda441bf6543~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_1429e6c427924064b77beda441bf6543~mv2.png)
![Medications that do not interact with other drugs](https://static.wixstatic.com/media/966baf_8ea74dd007c14bf3b35d5b46eefbd300~mv2.png/v1/fill/w_960,h_540,al_c,q_90,enc_auto/966baf_8ea74dd007c14bf3b35d5b46eefbd300~mv2.png)
Copyright 2024, CaferMed
Check out the video version of this podcast for a sneak peak of Cafer's Psychopharmacology 2nd edition, in the works for 2025.
Copyright 2024, CaferMed
Komentarze